Neurogene (NGNE) Tops Q2 EPS by 38c
Neurogene (NASDAQ: NGNE) reported Q2 EPS of ($1.05), $0.38 better than the analyst estimate of ($1.43).
For earnings history and earnings-related data on Neurogene (NGNE) click here.
Neurogene (NASDAQ: NGNE) reported Q2 EPS of ($1.05), $0.38 better than the analyst estimate of ($1.43).
For earnings history and earnings-related data on Neurogene (NGNE) click here.